CSIMarket
 

Akili Inc   (NASDAQ: AKLI)

Akili Inc 's

Competitiveness




 

AKLI Sales vs. its Competitors Q1 2024



Comparing the current results to its competitors, Akili Inc reported Revenue increase in the 1 quarter 2024 by 238.94 % year on year.
The sales growth was above Akili Inc 's competitors' average revenue growth of 12.79 %, achieved in the same quarter.

List of AKLI Competitors





Revenue Growth Comparisons




Net Income Comparison


Akili Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  AKLI Stock Performance Comparisons


Akili Inc 's Comment on Competition and Industry Peers


The company faces competition from other firms developing products similar to its current and potential future offerings.



  

Overall company Market Share Q1 2024

Due to outstanding performance in Overall company, revenue grew by 238.94 % Akili Inc improved its market share, to approximately 0.03 %.




<<  More on AKLI Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Akili Inc




Reunion Neuroscience Inc
Share Performance



0.00%
This Year



Reunion Neuroscience Inc
Profile

Reunion Neuroscience Inc is a company that operates on a business model focused on providing neuroscience-based solutions. They are committed to developing and commercializing novel therapeutics for improving brain health and addressing neurological disorders. Their business model involves conducting rigorous research, collaborating with industry partners, and bringing innovative products to market to meet the needs of patients and healthcare professionals.

More about Reunion Neuroscience Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 13.024 mill. $ 19.870 mill. $ -37.146 mill.


Definium Therapeutics Inc
Share Performance



-8.08%
30 Days



Definium Therapeutics Inc
Profile

Definium Therapeutics develops pharmaceutically optimized psychedelic drug candidates.

More about Definium Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,231.968 mill. $ - mill. $ -237.543 mill.


Lifestance Health Group Inc
Share Performance



+134.79%
One Year



Lifestance Health Group Inc
Profile

Lifestance Health Group Inc is a mental health care company that provides comprehensive outpatient services. Their business model focuses on delivering personalized, evidence-based treatments to individuals struggling with various mental health conditions. They aim to optimize patient outcomes by employing a collaborative, integrated approach that combines therapy, medication management, and innovative technology solutions.

More about Lifestance Health Group Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 5,092.633 mill. $ 1,494.791 mill. $ 23.197 mill.


P3 Health Partners Inc
Share Performance



-27.58%
This Quarter



P3 Health Partners Inc
Profile

P3 Health Partners Inc operates on a value-based care model, aiming to provide comprehensive, coordinated, and proactive healthcare services to patients. They focus on delivering personalized care through an interdisciplinary team including primary care physicians, specialists, care coordinators, and behavioral health professionals. P3 Health Partners Inc also aims to reduce healthcare costs by improving patient outcomes and preventing hospital readmissions through their collaborative and patient-centered approach.

More about P3 Health Partners Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 31.435 mill. $ 1,502.838 mill. $ -216.484 mill.


Teladoc Health Inc
Share Performance



+2.05%
Over The Past 5 Days



Teladoc Health Inc
Profile

Teladoc Health Inc is a telehealth company that operates a virtual healthcare delivery platform connecting patients with doctors via video consultations. The company generates revenue by charging patients, employers, and health plans a fee for its on-demand medical services. Teladoc's business model focuses on providing convenient, accessible, and cost-effective healthcare solutions, aiming to reduce the need for in-person doctor visits and improve patient outcomes.

More about Teladoc Health Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,157.130 mill. $ 2,514.453 mill. $ -171.147 mill.

Sources: Akili Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Akili Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.